Therma Bright (TSE:THRM) has released an update.
Therma Bright Inc. congratulates John Patton, Ph.D., Chairman of their strategic investment partner InStatin, on receiving the Charles G. Thiel Award for his contributions to respiratory drug delivery. Patton’s notable career includes founding several biotech companies and achieving major industry milestones. Therma Bright, which holds significant shares in InStatin and InVixa, is optimistic about their collaborative development of innovative inhalant solutions for lung conditions.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
